Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?
Cornelius J. Clancy, M. Hong Nguyen
Clinical Infectious Diseases (2020) Vol. 71, Iss. 10, pp. 2736-2743
Open Access | Times Cited: 274

Showing 1-25 of 274 citing articles:

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
Bradley J. Langford, Miranda So, Sumit Raybardhan, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 12, pp. 1622-1629
Open Access | Times Cited: 1442
Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study
Valerie M. Vaughn, Tejal Gandhi, Lindsay A Petty, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 10, pp. e533-e541
Open Access | Times Cited: 367
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
Marco Ripa, Laura Galli, Andrea Poli, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 3, pp. 451-457
Open Access | Times Cited: 327
Antimicrobial resistance and COVID-19: Intersections and implications
Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 287
Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge
Priya Nori, Kelsie Cowman, Victor Chen, et al.
Infection Control and Hospital Epidemiology (2020) Vol. 42, Iss. 1, pp. 84-88
Open Access | Times Cited: 279
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis
Kazem Ahmadikia, Seyed Jamal Hashemi, Sadegh Khodavaisy, et al.
Mycoses (2021) Vol. 64, Iss. 8, pp. 798-808
Open Access | Times Cited: 194
Fungal co-infection in COVID-19 patients: Should we be concerned?
Javier Pemán, Alba Ruiz‐Gaitán, Carolina García‐Vidal, et al.
Revista Iberoamericana de Micología (2020) Vol. 37, Iss. 2, pp. 41-46
Open Access | Times Cited: 183
Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?
Soumya Ghosh, Charné Bornman, Mai M. Zafer
Journal of Infection and Public Health (2021) Vol. 14, Iss. 5, pp. 555-560
Open Access | Times Cited: 160
Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients
Heba H. Mostafa, John A. Fissel, Brian Fanelli, et al.
mBio (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 157
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)
Ruwandi Kariyawasam, Danielle Julien, Dana C. Jelinski, et al.
Antimicrobial Resistance and Infection Control (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 156
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands
Zara Karami, Bram T. Knoop, Anton S. M. Dofferhoff, et al.
Infectious Diseases (2020) Vol. 53, Iss. 2, pp. 102-110
Open Access | Times Cited: 152
A Syndemic Perspective on the Management of Non-communicable Diseases Amid the COVID-19 Pandemic in Low- and Middle-Income Countries
Uday Narayan Yadav, Binod Rayamajhee, Sabuj Kanti Mistry, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 150
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 128
Biocide-tolerance and antibiotic-resistance in community environments and risk of direct transfers to humans: Unintended consequences of community-wide surface disinfecting during COVID-19?
Bo Chen, Jie Han, Han Dai, et al.
Environmental Pollution (2021) Vol. 283, pp. 117074-117074
Open Access | Times Cited: 113
Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern
Gabriela Abelenda-Alonso, Ariadna Padullés, Alexander Rombauts, et al.
Infection Control and Hospital Epidemiology (2020) Vol. 41, Iss. 11, pp. 1371-1372
Open Access | Times Cited: 134
Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic
Rafael Cantón, Desirèe Gijón, Patricia Ruíz-Garbajosa
Current Opinion in Critical Care (2020) Vol. 26, Iss. 5, pp. 433-441
Open Access | Times Cited: 111
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report
Eelco F. J. Meijer, Anton S. M. Dofferhoff, Oscar Hoiting, et al.
Journal of Fungi (2020) Vol. 6, Iss. 2, pp. 79-79
Open Access | Times Cited: 104
Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?
Eric Pelfrene, Radu Botgros, Marco Cavaleri
Antimicrobial Resistance and Infection Control (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 103
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals
Ronald Andrew Seaton, Cheryl Gibbons, Lesley Cooper, et al.
Journal of Infection (2020) Vol. 81, Iss. 6, pp. 952-960
Open Access | Times Cited: 102
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID
Jorge Calderón‐Parra, A. Muiño-Míguez, Alejandro David Bendala Estrada, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251340-e0251340
Open Access | Times Cited: 100
COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review
Carmen A. Pfortmueller, Thibaud Spinetti, Richard D. Urman, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 35, Iss. 3, pp. 351-368
Open Access | Times Cited: 98
Bacterial co-infections and antibiotic resistance in patients with COVID-19
Hassan Mahmoudi
DOAJ (DOAJ: Directory of Open Access Journals) (2020)
Open Access | Times Cited: 98
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions
Robert Root‐Bernstein
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2108-2108
Open Access | Times Cited: 98
PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates
Cornelius J. Clancy, Deanna J. Buehrle, M. Hong Nguyen
JAC-Antimicrobial Resistance (2020) Vol. 2, Iss. 3
Open Access | Times Cited: 93
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance
Jesús Rodríguez‐Baño, Gian María Rossolini, Constance Schultsz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 10, pp. 1122-1129
Open Access | Times Cited: 92
Page 1 - Next Page

Scroll to top